EPS Bio Technology Corp. (TPEX:4183)
Taiwan
· Delayed Price · Currency is TWD 20.90
+0.80 (3.98%)
Jun 13, 2025, 1:06 PM CST
EPS Bio Technology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 17.31 | 20.99 | 25.36 | 18.64 | 31.7 | Upgrade
|
Depreciation & Amortization | 14.18 | 14.9 | 16.62 | 17.85 | 17.15 | Upgrade
|
Other Amortization | 0.42 | 0.6 | 0.69 | 0.73 | 0.69 | Upgrade
|
Loss (Gain) From Sale of Assets | - | 0.26 | - | - | - | Upgrade
|
Provision & Write-off of Bad Debts | -1.89 | 0.16 | 2.61 | 1.2 | 1.29 | Upgrade
|
Other Operating Activities | -15.52 | 5.45 | -10.33 | 7.63 | 7.43 | Upgrade
|
Change in Accounts Receivable | -51.18 | -17.08 | 20.8 | -21.49 | 25.03 | Upgrade
|
Change in Inventory | -8.39 | 10.86 | -4.89 | -35.46 | -2.04 | Upgrade
|
Change in Accounts Payable | 5.84 | 16.42 | -23.15 | 24.82 | -5.99 | Upgrade
|
Change in Unearned Revenue | 9.96 | 3.97 | -27.69 | 22.7 | 2.56 | Upgrade
|
Change in Other Net Operating Assets | -3.07 | -1.35 | 4.98 | -4.54 | 2.09 | Upgrade
|
Operating Cash Flow | -32.34 | 55.17 | 5 | 32.08 | 79.91 | Upgrade
|
Operating Cash Flow Growth | - | 1003.86% | -84.42% | -59.85% | 265.74% | Upgrade
|
Capital Expenditures | -13.9 | -9.48 | -14.95 | -11.75 | -6.49 | Upgrade
|
Sale of Property, Plant & Equipment | 0.01 | - | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -0.51 | - | - | -0.39 | -0.5 | Upgrade
|
Other Investing Activities | - | - | 0.04 | - | - | Upgrade
|
Investing Cash Flow | -14.4 | -9.48 | -14.92 | -12.14 | -6.98 | Upgrade
|
Long-Term Debt Repaid | -5.68 | -5.59 | -5.93 | -5.46 | -5.36 | Upgrade
|
Total Debt Repaid | -5.68 | -5.59 | -5.93 | -5.46 | -5.36 | Upgrade
|
Net Debt Issued (Repaid) | -5.68 | -5.59 | -5.93 | -5.46 | -5.36 | Upgrade
|
Common Dividends Paid | -19.04 | -23.32 | -16.66 | -28.56 | -16.66 | Upgrade
|
Financing Cash Flow | -24.72 | -28.91 | -22.59 | -34.02 | -22.02 | Upgrade
|
Foreign Exchange Rate Adjustments | 5.11 | -0.15 | 7.75 | -4.38 | -4.81 | Upgrade
|
Net Cash Flow | -66.35 | 16.63 | -24.76 | -18.45 | 46.09 | Upgrade
|
Free Cash Flow | -46.24 | 45.69 | -9.96 | 20.34 | 73.42 | Upgrade
|
Free Cash Flow Growth | - | - | - | -72.30% | 936.43% | Upgrade
|
Free Cash Flow Margin | -10.25% | 9.72% | -2.15% | 4.23% | 15.37% | Upgrade
|
Free Cash Flow Per Share | -1.94 | 1.91 | -0.42 | 0.85 | 3.07 | Upgrade
|
Cash Interest Paid | 2.05 | 2.14 | 2.13 | 2.18 | 2.29 | Upgrade
|
Cash Income Tax Paid | 6.59 | 6.48 | 3.77 | 4.32 | 4.96 | Upgrade
|
Levered Free Cash Flow | -60.98 | 39.95 | -22.31 | 15.26 | 63.31 | Upgrade
|
Unlevered Free Cash Flow | -59.7 | 41.29 | -20.98 | 16.63 | 64.75 | Upgrade
|
Change in Net Working Capital | 63.26 | -19.7 | 33.34 | 10.48 | -26.3 | Upgrade
|
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.